APA aipamena

Beaumont, J. L., Salsman, J. M., Diaz, J., Deen, K., McCann, L., Powles, T., . . . Cella, D. (2016). Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Pazopanib Versus Sunitinib in Patients With Renal Cell Carcinoma. Cancer.

Chicago Style aipamena

Beaumont, Jennifer L., John M. Salsman, Jose Diaz, Keith Deen, Lauren McCann, Thomas Powles, Michelle D. Hackshaw, Robert J. Motzer, and David Cella. "Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Pazopanib Versus Sunitinib in Patients With Renal Cell Carcinoma." Cancer 2016.

MLA aipamena

Beaumont, Jennifer L., et al. "Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Pazopanib Versus Sunitinib in Patients With Renal Cell Carcinoma." Cancer 2016.